Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 47 entries
Sorted by: Best Match Show Resources per page
[In Process Citation].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)

Baena-Cagnani CE, Larenas-Linnemann D.
PMID: 24941972
Rev Alerg Mex. 2014;61:S2.

No abstract available.

Cite
Baena-Cagnani CE, Larenas-Linnemann D. Prefacio. [In Process Citation]. Rev Alerg Mex. 2014;61:S2
Baena-Cagnani, C. E., & Larenas-Linnemann, D. (2014). Prefacio. [In Process Citation]. Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993), 61S2.
Baena-Cagnani, Carlos E, and Larenas-Linnemann, Désirée. "Prefacio." [In Process Citation]. Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) vol. 61 (2014): S2.
Baena-Cagnani CE, Larenas-Linnemann D. Prefacio. [In Process Citation]. Rev Alerg Mex. 2014;61:S2. Spanish. PMID: 24941972.
Copy Download .nbib Format: NLM
How an online survey on the treatment of allergic rhinitis and its impact on asthma (ARIA) detected specialty-specific knowledge-gaps.

The World Allergy Organization journal

Larenas Linnemann DE, Medina Ávalos MA, Lozano Sáenz J.
PMID: 26023324
World Allergy Organ J. 2015 May 19;8(1):18. doi: 10.1186/s40413-015-0064-1. eCollection 2015.

BACKGROUND: To enhance the dissemination of the ARIA document (Allergic rhinitis (AR) and its impact on asthma) in Mexico, a Working Group composed of 35 specialists of 8 professional medical societies developed a transculturized ARIA México 2014 guideline. The...

Cite
Larenas Linnemann DE, Medina Ávalos MA, Lozano Sáenz J. How an online survey on the treatment of allergic rhinitis and its impact on asthma (ARIA) detected specialty-specific knowledge-gaps. World Allergy Organ J. 2015;8(1):18doi: 10.1186/s40413-015-0064-1.
Larenas Linnemann, D. E., Medina Ávalos, M. A., & Lozano Sáenz, J. (2015). How an online survey on the treatment of allergic rhinitis and its impact on asthma (ARIA) detected specialty-specific knowledge-gaps. The World Allergy Organization journal, 8(1), 18. https://doi.org/10.1186/s40413-015-0064-1
Larenas Linnemann, Désirée Es, et al. "How an online survey on the treatment of allergic rhinitis and its impact on asthma (ARIA) detected specialty-specific knowledge-gaps." The World Allergy Organization journal vol. 8,1 (2015): 18. doi: https://doi.org/10.1186/s40413-015-0064-1
Larenas Linnemann DE, Medina Ávalos MA, Lozano Sáenz J. How an online survey on the treatment of allergic rhinitis and its impact on asthma (ARIA) detected specialty-specific knowledge-gaps. World Allergy Organ J. 2015 May 19;8(1):18. doi: 10.1186/s40413-015-0064-1. eCollection 2015. PMID: 26023324; PMCID: PMC4436974.
Copy Download .nbib Format: NLM
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma.

The journal of allergy and clinical immunology. In practice

Porsbjerg CM, Menzies-Gow AN, Tran TN, Murray RB, Unni B, Audrey Ang SL, Alacqua M, Al-Ahmad M, Al-Lehebi R, Altraja A, Belevskiy AS, Björnsdóttir US, Bourdin A, Busby J, Canonica GW, Christoff GC, Cosio BG, Costello RW, FitzGerald JM, Fonseca JA, Hansen S, Heaney LG, Heffler E, Hew M, Iwanaga T, Jackson DJ, Kocks JWH, Kallieri M, Bruce Ko HK, Koh MS, Larenas-Linnemann D, Lehtimäki LA, Loukides S, Lugogo N, Maspero J, Papaioannou AI, Perez-de-Llano L, Pitrez PM, Popov TA, Rasmussen LM, Rhee CK, Sadatsafavi M, Schmid J, Siddiqui S, Taillé C, Taube C, Torres-Duque CA, Ulrik C, Upham JW, Wang E, Wechsler ME, Bulathsinhala L, Carter V, Chaudhry I, Eleangovan N, Hosseini N, Rowlands MA, Price D, van Boven JF.
PMID: 34990866
J Allergy Clin Immunol Pract. 2022 Jan 03; doi: 10.1016/j.jaip.2021.12.027. Epub 2022 Jan 03.

BACKGROUND: Regulatory bodies have approved five biologics for severe asthma. However, regional differences in accessibility may limit the global potential for personalized medicine.OBJECTIVE: To compare global differences in ease-of-access to biologics.METHODS: In April 2021, national prescription criteria for omalizumab,...

Cite
Porsbjerg CM, Menzies-Gow AN, Tran TN, et al. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma. J Allergy Clin Immunol Pract. 2022;doi: 10.1016/j.jaip.2021.12.027.
Porsbjerg, C. M., Menzies-Gow, A. N., Tran, T. N., Murray, R. B., Unni, B., Audrey Ang, S. L., Alacqua, M., Al-Ahmad, M., Al-Lehebi, R., Altraja, A., Belevskiy, A. S., Björnsdóttir, U. S., Bourdin, A., Busby, J., Canonica, G. W., Christoff, G. C., Cosio, B. G., Costello, R. W., FitzGerald, J. M., Fonseca, J. A., Hansen, S., Heaney, L. G., Heffler, E., Hew, M., Iwanaga, T., Jackson, D. J., Kocks, J. W. H., Kallieri, M., Bruce Ko, H. K., Koh, M. S., Larenas-Linnemann, D., Lehtimäki, L. A., Loukides, S., Lugogo, N., Maspero, J., Papaioannou, A. I., Perez-de-Llano, L., Pitrez, P. M., Popov, T. A., Rasmussen, L. M., Rhee, C. K., Sadatsafavi, M., Schmid, J., Siddiqui, S., Taillé, C., Taube, C., Torres-Duque, C. A., Ulrik, C., Upham, J. W., Wang, E., Wechsler, M. E., Bulathsinhala, L., Carter, V., Chaudhry, I., Eleangovan, N., Hosseini, N., Rowlands, M. A., Price, D., & van Boven, J. F. (2022). Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma. The journal of allergy and clinical immunology. In practice, . https://doi.org/10.1016/j.jaip.2021.12.027
Porsbjerg, Celeste M, et al. "Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma." The journal of allergy and clinical immunology. In practice vol. (2022). doi: https://doi.org/10.1016/j.jaip.2021.12.027
Porsbjerg CM, Menzies-Gow AN, Tran TN, Murray RB, Unni B, Audrey Ang SL, Alacqua M, Al-Ahmad M, Al-Lehebi R, Altraja A, Belevskiy AS, Björnsdóttir US, Bourdin A, Busby J, Canonica GW, Christoff GC, Cosio BG, Costello RW, FitzGerald JM, Fonseca JA, Hansen S, Heaney LG, Heffler E, Hew M, Iwanaga T, Jackson DJ, Kocks JWH, Kallieri M, Bruce Ko HK, Koh MS, Larenas-Linnemann D, Lehtimäki LA, Loukides S, Lugogo N, Maspero J, Papaioannou AI, Perez-de-Llano L, Pitrez PM, Popov TA, Rasmussen LM, Rhee CK, Sadatsafavi M, Schmid J, Siddiqui S, Taillé C, Taube C, Torres-Duque CA, Ulrik C, Upham JW, Wang E, Wechsler ME, Bulathsinhala L, Carter V, Chaudhry I, Eleangovan N, Hosseini N, Rowlands MA, Price D, van Boven JF. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma. J Allergy Clin Immunol Pract. 2022 Jan 03; doi: 10.1016/j.jaip.2021.12.027. Epub 2022 Jan 03. PMID: 34990866.
Copy Download .nbib Format: NLM
Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®.

Clinical and translational allergy

Sousa-Pinto B, Eklund P, Pfaar O, Klimek L, Zuberbier T, Czarlewski W, Bédard A, Bindslev-Jensen C, Bedbrook A, Bosnic-Anticevich S, Brussino L, Cardona V, Cruz AA, de Vries G, Devillier P, Fokkens WJ, Fuentes-Pérez JM, Gemicioğlu B, Haahtela T, Huerta-Villalobos YR, Ivancevich JC, Kull I, Kuna P, Kvedariene V, Larenas Linnemann DE, Laune D, Makris M, Melén E, Morais-Almeida M, Mösges R, Mullol J, O'Hehir RE, Papadopoulos NG, Pereira AM, Prokopakis EP, Psarros F, Regateiro FS, Reitsma S, Samolinski B, Scichilone N, da Silva J, Stellato C, Todo-Bom A, Tomazic PV, Salmi ST, Valero A, Valiulis A, Valovirta E, van Eerd M, Ventura MT, Yorgancioglu A, Basagaña X, Antó JM, Bousquet J, Fonseca JA.
PMID: 34567526
Clin Transl Allergy. 2021 Sep 19;11(7):e12062. doi: 10.1002/clt2.12062. eCollection 2021 Aug.

BACKGROUND: MASK-air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities using visual analog scales (VASs). We aimed to assess the concurrent validity, reliability, and responsiveness of...

Cite
Sousa-Pinto B, Eklund P, Pfaar O, et al. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®. Clin Transl Allergy. 2021;11(7):e12062doi: 10.1002/clt2.12062.
Sousa-Pinto, B., Eklund, P., Pfaar, O., Klimek, L., Zuberbier, T., Czarlewski, W., Bédard, A., Bindslev-Jensen, C., Bedbrook, A., Bosnic-Anticevich, S., Brussino, L., Cardona, V., Cruz, A. A., de Vries, G., Devillier, P., Fokkens, W. J., Fuentes-Pérez, J. M., Gemicioğlu, B., Haahtela, T., Huerta-Villalobos, Y. R., Ivancevich, J. C., Kull, I., Kuna, P., Kvedariene, V., Larenas Linnemann, D. E., Laune, D., Makris, M., Melén, E., Morais-Almeida, M., Mösges, R., Mullol, J., O'Hehir, R. E., Papadopoulos, N. G., Pereira, A. M., Prokopakis, E. P., Psarros, F., Regateiro, F. S., Reitsma, S., Samolinski, B., Scichilone, N., da Silva, J., Stellato, C., Todo-Bom, A., Tomazic, P. V., Salmi, S. T., Valero, A., Valiulis, A., Valovirta, E., van Eerd, M., Ventura, M. T., Yorgancioglu, A., Basagaña, X., Antó, J. M., Bousquet, J., & Fonseca, J. A. (2021). Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®. Clinical and translational allergy, 11(7), e12062. https://doi.org/10.1002/clt2.12062
Sousa-Pinto, Bernardo, et al. "Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®." Clinical and translational allergy vol. 11,7 (2021): e12062. doi: https://doi.org/10.1002/clt2.12062
Sousa-Pinto B, Eklund P, Pfaar O, Klimek L, Zuberbier T, Czarlewski W, Bédard A, Bindslev-Jensen C, Bedbrook A, Bosnic-Anticevich S, Brussino L, Cardona V, Cruz AA, de Vries G, Devillier P, Fokkens WJ, Fuentes-Pérez JM, Gemicioğlu B, Haahtela T, Huerta-Villalobos YR, Ivancevich JC, Kull I, Kuna P, Kvedariene V, Larenas Linnemann DE, Laune D, Makris M, Melén E, Morais-Almeida M, Mösges R, Mullol J, O'Hehir RE, Papadopoulos NG, Pereira AM, Prokopakis EP, Psarros F, Regateiro FS, Reitsma S, Samolinski B, Scichilone N, da Silva J, Stellato C, Todo-Bom A, Tomazic PV, Salmi ST, Valero A, Valiulis A, Valovirta E, van Eerd M, Ventura MT, Yorgancioglu A, Basagaña X, Antó JM, Bousquet J, Fonseca JA. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®. Clin Transl Allergy. 2021 Sep 19;11(7):e12062. doi: 10.1002/clt2.12062. eCollection 2021 Aug. PMID: 34567526; PMCID: PMC8449952.
Copy Download .nbib Format: NLM
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1).

Journal of thoracic disease

Bousquet J, Pham-Thi N, Bedbrook A, Agache I, Annesi-Maesano I, Ansotegui I, Anto JM, Bachert C, Benveniste S, Bewick M, Billo N, Bosnic-Anticevich S, Bosse I, Brusselle G, Calderon MA, Canonica GW, Caraballo L, Cardona V, Carriazo AM, Cash E, Cecchi L, Chu DK, Colgan E, Costa E, Cruz AA, Czarlewski W, Durham S, Ebisawa M, Erhola M, Fauquert JL, Fokkens WJ, Fonseca JA, Guldemond N, Iinuma T, Illario M, Klimek L, Kuna P, Kvedariene V, Larenas-Linneman D, Laune D, Le LTT, Lourenço O, Malva JO, Marien G, Menditto E, Mullol J, Münter L, Okamoto Y, Onorato GL, Papadopoulos NG, Perala M, Pfaar O, Phillips A, Phillips J, Pinnock H, Portejoie F, Quinones-Delgado P, Rolland C, Rodts U, Samolinski B, Sanchez-Borges M, Schünemann HJ, Shamji M, Somekh D, Togias A, Toppila-Salmi S, Tsiligianni I, Usmani O, Walker S, Wallace D, Valiulis A, Van der Kleij R, Ventura MT, Williams S, Yorgancioglu A, Zuberbier T.
PMID: 31559071
J Thorac Dis. 2019 Aug;11(8):3633-3642. doi: 10.21037/jtd.2019.08.64.

No abstract available.

Cite
Bousquet J, Pham-Thi N, Bedbrook A, et al. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1). J Thorac Dis. 2019;11(8):3633-3642doi: 10.21037/jtd.2019.08.64.
Bousquet, J., Pham-Thi, N., Bedbrook, A., Agache, I., Annesi-Maesano, I., Ansotegui, I., Anto, J. M., Bachert, C., Benveniste, S., Bewick, M., Billo, N., Bosnic-Anticevich, S., Bosse, I., Brusselle, G., Calderon, M. A., Canonica, G. W., Caraballo, L., Cardona, V., Carriazo, A. M., Cash, E., Cecchi, L., Chu, D. K., Colgan, E., Costa, E., Cruz, A. A., Czarlewski, W., Durham, S., Ebisawa, M., Erhola, M., Fauquert, J. L., Fokkens, W. J., Fonseca, J. A., Guldemond, N., Iinuma, T., Illario, M., Klimek, L., Kuna, P., Kvedariene, V., Larenas-Linneman, D., Laune, D., Le, L. T. T., Lourenço, O., Malva, J. O., Marien, G., Menditto, E., Mullol, J., Münter, L., Okamoto, Y., Onorato, G. L., Papadopoulos, N. G., Perala, M., Pfaar, O., Phillips, A., Phillips, J., Pinnock, H., Portejoie, F., Quinones-Delgado, P., Rolland, C., Rodts, U., Samolinski, B., Sanchez-Borges, M., Schünemann, H. J., Shamji, M., Somekh, D., Togias, A., Toppila-Salmi, S., Tsiligianni, I., Usmani, O., Walker, S., Wallace, D., Valiulis, A., Van der Kleij, R., Ventura, M. T., Williams, S., Yorgancioglu, A., & Zuberbier, T. (2019). Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1). Journal of thoracic disease, 11(8), 3633-3642. https://doi.org/10.21037/jtd.2019.08.64
Bousquet, Jean, et al. "Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1)." Journal of thoracic disease vol. 11,8 (2019): 3633-3642. doi: https://doi.org/10.21037/jtd.2019.08.64
Bousquet J, Pham-Thi N, Bedbrook A, Agache I, Annesi-Maesano I, Ansotegui I, Anto JM, Bachert C, Benveniste S, Bewick M, Billo N, Bosnic-Anticevich S, Bosse I, Brusselle G, Calderon MA, Canonica GW, Caraballo L, Cardona V, Carriazo AM, Cash E, Cecchi L, Chu DK, Colgan E, Costa E, Cruz AA, Czarlewski W, Durham S, Ebisawa M, Erhola M, Fauquert JL, Fokkens WJ, Fonseca JA, Guldemond N, Iinuma T, Illario M, Klimek L, Kuna P, Kvedariene V, Larenas-Linneman D, Laune D, Le LTT, Lourenço O, Malva JO, Marien G, Menditto E, Mullol J, Münter L, Okamoto Y, Onorato GL, Papadopoulos NG, Perala M, Pfaar O, Phillips A, Phillips J, Pinnock H, Portejoie F, Quinones-Delgado P, Rolland C, Rodts U, Samolinski B, Sanchez-Borges M, Schünemann HJ, Shamji M, Somekh D, Togias A, Toppila-Salmi S, Tsiligianni I, Usmani O, Walker S, Wallace D, Valiulis A, Van der Kleij R, Ventura MT, Williams S, Yorgancioglu A, Zuberbier T. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1). J Thorac Dis. 2019 Aug;11(8):3633-3642. doi: 10.21037/jtd.2019.08.64. PMID: 31559071; PMCID: PMC6753463.
Copy Download .nbib Format: NLM
Beyond eosinophilia: inflammatory patterns in patients with asthma.

The Journal of asthma : official journal of the Association for the Care of Asthma

Bedolla-Barajas M, Morales-Romero J, Hernández-Colín DD, Larenas-Linnemann D, Mariscal-Castro J, Flores-Razo MM, Bedolla-Pulido A.
PMID: 33203290
J Asthma. 2020 Dec 07;1-16. doi: 10.1080/02770903.2020.1852413. Epub 2020 Dec 07.

No abstract available.

Cite
Bedolla-Barajas M, Morales-Romero J, Hernández-Colín DD, et al. Beyond eosinophilia: inflammatory patterns in patients with asthma. J Asthma. 2020;1-16doi: 10.1080/02770903.2020.1852413.
Bedolla-Barajas, M., Morales-Romero, J., Hernández-Colín, D. D., Larenas-Linnemann, D., Mariscal-Castro, J., Flores-Razo, M. M., & Bedolla-Pulido, A. (2020). Beyond eosinophilia: inflammatory patterns in patients with asthma. The Journal of asthma : official journal of the Association for the Care of Asthma, 1-16. https://doi.org/10.1080/02770903.2020.1852413
Bedolla-Barajas, Martín, et al. "Beyond eosinophilia: inflammatory patterns in patients with asthma." The Journal of asthma : official journal of the Association for the Care of Asthma vol. (2020): 1-16. doi: https://doi.org/10.1080/02770903.2020.1852413
Bedolla-Barajas M, Morales-Romero J, Hernández-Colín DD, Larenas-Linnemann D, Mariscal-Castro J, Flores-Razo MM, Bedolla-Pulido A. Beyond eosinophilia: inflammatory patterns in patients with asthma. J Asthma. 2020 Dec 07;1-16. doi: 10.1080/02770903.2020.1852413. Epub 2020 Dec 07. PMID: 33203290.
Copy Download .nbib Format: NLM
Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines.

The World Allergy Organization journal

Larenas-Linnemann D, Rodríguez-Pérez N, Luna-Pech JA, Rodríguez-González M, Blandón-Vijil MV, Del-Río-Navarro BE, Costa-Domínguez MDC, Navarrete-Rodríguez EM, Macouzet-Sánchez C, Ortega-Martell JA, Pozo-Beltrán CF, Estrada-Cardona A, Arias-Cruz A, Rodríguez Galván KG, Brito-Díaz H, Canseco-Raymundo MDR, Castelán-Chávez EE, Escalante-Domínguez AJ, Gálvez-Romero JL, Gómez-Vera J, González-Díaz SN, Guerrero-Núñez MGB, Hernández-Colín DD, Macías-Weinmann A, Mendoza-Hernández DA, Meneses-Sánchez NA, Mogica-Martínez MD, Moncayo-Coello CV, Montiel-Herrera JM, O'Farril-Romanillos PM, Onuma-Takane E, Ortega-Cisneros M, Rangel-Garza L, Stone-Aguilar H, Torres-Lozano C, Venegas-Montoya E, Wakida-Kusunoki G, Partida-Gaytán A, López-García AI, Macías-Robles AP, Ambriz-Moreno MJ, Azamar-Jácome AA, Beltrán-De Paz CY, Caballero-López C, Fernández de Córdova-Aguirre JC, Fernández-Soto JR, Lozano-Sáenz JS, Oyoqui-Flores JJ, Osorio-Escamilla RE, Ramírez-Jiménez F, Rivero-Yeverino D, Martínez Infante E, Medina-Ávalos MA.
PMID: 32884611
World Allergy Organ J. 2020 Aug 21;13(8):100444. doi: 10.1016/j.waojou.2020.100444. eCollection 2020 Aug.

BACKGROUND: Allergen immunotherapy (AIT) has a longstanding history and still remains the only disease-changing treatment for allergic rhinitis and asthma. Over the years 2 different schools have developed their strategies: the United States (US) and the European. Allergen extracts...

Cite
Larenas-Linnemann D, Rodríguez-Pérez N, Luna-Pech JA, et al. Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines. World Allergy Organ J. 2020;13(8):100444doi: 10.1016/j.waojou.2020.100444.
Larenas-Linnemann, D., Rodríguez-Pérez, N., Luna-Pech, J. A., Rodríguez-González, M., Blandón-Vijil, M. V., Del-Río-Navarro, B. E., Costa-Domínguez, M. D. C., Navarrete-Rodríguez, E. M., Macouzet-Sánchez, C., Ortega-Martell, J. A., Pozo-Beltrán, C. F., Estrada-Cardona, A., Arias-Cruz, A., Rodríguez Galván, K. G., Brito-Díaz, H., Canseco-Raymundo, M. D. R., Castelán-Chávez, E. E., Escalante-Domínguez, A. J., Gálvez-Romero, J. L., Gómez-Vera, J., González-Díaz, S. N., Guerrero-Núñez, M. G. B., Hernández-Colín, D. D., Macías-Weinmann, A., Mendoza-Hernández, D. A., Meneses-Sánchez, N. A., Mogica-Martínez, M. D., Moncayo-Coello, C. V., Montiel-Herrera, J. M., O'Farril-Romanillos, P. M., Onuma-Takane, E., Ortega-Cisneros, M., Rangel-Garza, L., Stone-Aguilar, H., Torres-Lozano, C., Venegas-Montoya, E., Wakida-Kusunoki, G., Partida-Gaytán, A., López-García, A. I., Macías-Robles, A. P., Ambriz-Moreno, M. J., Azamar-Jácome, A. A., Beltrán-De Paz, C. Y., Caballero-López, C., Fernández de Córdova-Aguirre, J. C., Fernández-Soto, J. R., Lozano-Sáenz, J. S., Oyoqui-Flores, J. J., Osorio-Escamilla, R. E., Ramírez-Jiménez, F., Rivero-Yeverino, D., Martínez Infante, E., & Medina-Ávalos, M. A. (2020). Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines. The World Allergy Organization journal, 13(8), 100444. https://doi.org/10.1016/j.waojou.2020.100444
Larenas-Linnemann, Désirée, et al. "Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines." The World Allergy Organization journal vol. 13,8 (2020): 100444. doi: https://doi.org/10.1016/j.waojou.2020.100444
Larenas-Linnemann D, Rodríguez-Pérez N, Luna-Pech JA, Rodríguez-González M, Blandón-Vijil MV, Del-Río-Navarro BE, Costa-Domínguez MDC, Navarrete-Rodríguez EM, Macouzet-Sánchez C, Ortega-Martell JA, Pozo-Beltrán CF, Estrada-Cardona A, Arias-Cruz A, Rodríguez Galván KG, Brito-Díaz H, Canseco-Raymundo MDR, Castelán-Chávez EE, Escalante-Domínguez AJ, Gálvez-Romero JL, Gómez-Vera J, González-Díaz SN, Guerrero-Núñez MGB, Hernández-Colín DD, Macías-Weinmann A, Mendoza-Hernández DA, Meneses-Sánchez NA, Mogica-Martínez MD, Moncayo-Coello CV, Montiel-Herrera JM, O'Farril-Romanillos PM, Onuma-Takane E, Ortega-Cisneros M, Rangel-Garza L, Stone-Aguilar H, Torres-Lozano C, Venegas-Montoya E, Wakida-Kusunoki G, Partida-Gaytán A, López-García AI, Macías-Robles AP, Ambriz-Moreno MJ, Azamar-Jácome AA, Beltrán-De Paz CY, Caballero-López C, Fernández de Córdova-Aguirre JC, Fernández-Soto JR, Lozano-Sáenz JS, Oyoqui-Flores JJ, Osorio-Escamilla RE, Ramírez-Jiménez F, Rivero-Yeverino D, Martínez Infante E, Medina-Ávalos MA. Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines. World Allergy Organ J. 2020 Aug 21;13(8):100444. doi: 10.1016/j.waojou.2020.100444. eCollection 2020 Aug. PMID: 32884611; PMCID: PMC7451623.
Copy Download .nbib Format: NLM
Enhancing innate immunity against virus in times of COVID-19: Trying to untangle facts from fictions.

The World Allergy Organization journal

Larenas-Linnemann D, Rodríguez-Pérez N, Arias-Cruz A, Blandón-Vijil MV, Del Río-Navarro BE, Estrada-Cardona A, Gereda JE, Luna-Pech JA, Navarrete-Rodríguez EM, Onuma-Takane E, Pozo-Beltrán CF, Rojo-Gutiérrez MI.
PMID: 33072240
World Allergy Organ J. 2020 Nov;13(11):100476. doi: 10.1016/j.waojou.2020.100476. Epub 2020 Oct 09.

INTRODUCTION: In light of the current COVID-19 pandemic, during which the world is confronted with a new, highly contagious virus that suppresses innate immunity as one of its initial virulence mechanisms, thus escaping from first-line human defense mechanisms, enhancing...

Cite
Larenas-Linnemann D, Rodríguez-Pérez N, Arias-Cruz A, et al. Enhancing innate immunity against virus in times of COVID-19: Trying to untangle facts from fictions. World Allergy Organ J. 2020;13(11):100476doi: 10.1016/j.waojou.2020.100476.
Larenas-Linnemann, D., Rodríguez-Pérez, N., Arias-Cruz, A., Blandón-Vijil, M. V., Del Río-Navarro, B. E., Estrada-Cardona, A., Gereda, J. E., Luna-Pech, J. A., Navarrete-Rodríguez, E. M., Onuma-Takane, E., Pozo-Beltrán, C. F., & Rojo-Gutiérrez, M. I. (2020). Enhancing innate immunity against virus in times of COVID-19: Trying to untangle facts from fictions. The World Allergy Organization journal, 13(11), 100476. https://doi.org/10.1016/j.waojou.2020.100476
Larenas-Linnemann, Désirée, et al. "Enhancing innate immunity against virus in times of COVID-19: Trying to untangle facts from fictions." The World Allergy Organization journal vol. 13,11 (2020): 100476. doi: https://doi.org/10.1016/j.waojou.2020.100476
Larenas-Linnemann D, Rodríguez-Pérez N, Arias-Cruz A, Blandón-Vijil MV, Del Río-Navarro BE, Estrada-Cardona A, Gereda JE, Luna-Pech JA, Navarrete-Rodríguez EM, Onuma-Takane E, Pozo-Beltrán CF, Rojo-Gutiérrez MI. Enhancing innate immunity against virus in times of COVID-19: Trying to untangle facts from fictions. World Allergy Organ J. 2020 Nov;13(11):100476. doi: 10.1016/j.waojou.2020.100476. Epub 2020 Oct 09. PMID: 33072240; PMCID: PMC7546230.
Copy Download .nbib Format: NLM
Development and validation of combined symptom-medication scores for allergic rhinitis.

Allergy

Sousa-Pinto B, Azevedo LF, Jutel M, Agache I, Canonica GW, Czarlewski W, Papadopoulos NG, Bergmann KC, Devillier P, Laune D, Klimek L, Anto A, Anto JM, Eklund P, Almeida R, Bedbrook A, Bosnic-Anticevich S, Brough HA, Brussino L, Cardona V, Casale T, Cecchi L, Charpin D, Chivato T, Costa EM, Cruz AA, Dramburg S, Durham SR, De Feo G, Gerth van Wijk R, Fokkens WJ, Gemicioglu B, Haahtela T, Illario M, Ivancevich JC, Kvedariene V, Kuna P, Larenas-Linnemann DE, Makris M, Mathieu-Dupas E, Melén E, Morais-Almeida M, Mösges R, Mullol J, Nadeau KC, Pham-Thi N, O'Hehir R, Regateiro FS, Reitsma S, Samolinski B, Sheikh A, Stellato C, Todo-Bom A, Tomazic PV, Toppila-Salmi S, Valero A, Valiulis A, Ventura MT, Wallace D, Waserman S, Yorgancioglu A, De Vries G, van Eerd M, Zieglmayer P, Zuberbier T, Pfaar O, Almeida Fonseca J, Bousquet J.
PMID: 34932829
Allergy. 2021 Dec 21; doi: 10.1111/all.15199. Epub 2021 Dec 21.

BACKGROUND: Validated combined symptom-medication scores (CSMSs) are needed to investigate the effects of allergic rhinitis treatments. This study aimed to use real-life data from the MASK-airMETHODS: We used MASK-airRESULTS: We assessed 317,176 days of MASK-airCONCLUSION: The mixed CSMS and...

Cite
Sousa-Pinto B, Azevedo LF, Jutel M, et al. Development and validation of combined symptom-medication scores for allergic rhinitis. Allergy. 2021;doi: 10.1111/all.15199.
Sousa-Pinto, B., Azevedo, L. F., Jutel, M., Agache, I., Canonica, G. W., Czarlewski, W., Papadopoulos, N. G., Bergmann, K. C., Devillier, P., Laune, D., Klimek, L., Anto, A., Anto, J. M., Eklund, P., Almeida, R., Bedbrook, A., Bosnic-Anticevich, S., Brough, H. A., Brussino, L., Cardona, V., Casale, T., Cecchi, L., Charpin, D., Chivato, T., Costa, E. M., Cruz, A. A., Dramburg, S., Durham, S. R., De Feo, G., Gerth van Wijk, R., Fokkens, W. J., Gemicioglu, B., Haahtela, T., Illario, M., Ivancevich, J. C., Kvedariene, V., Kuna, P., Larenas-Linnemann, D. E., Makris, M., Mathieu-Dupas, E., Melén, E., Morais-Almeida, M., Mösges, R., Mullol, J., Nadeau, K. C., Pham-Thi, N., O'Hehir, R., Regateiro, F. S., Reitsma, S., Samolinski, B., Sheikh, A., Stellato, C., Todo-Bom, A., Tomazic, P. V., Toppila-Salmi, S., Valero, A., Valiulis, A., Ventura, M. T., Wallace, D., Waserman, S., Yorgancioglu, A., De Vries, G., van Eerd, M., Zieglmayer, P., Zuberbier, T., Pfaar, O., Almeida Fonseca, J., & Bousquet, J. (2021). Development and validation of combined symptom-medication scores for allergic rhinitis. Allergy, . https://doi.org/10.1111/all.15199
Sousa-Pinto, Bernardo, et al. "Development and validation of combined symptom-medication scores for allergic rhinitis." Allergy vol. (2021). doi: https://doi.org/10.1111/all.15199
Sousa-Pinto B, Azevedo LF, Jutel M, Agache I, Canonica GW, Czarlewski W, Papadopoulos NG, Bergmann KC, Devillier P, Laune D, Klimek L, Anto A, Anto JM, Eklund P, Almeida R, Bedbrook A, Bosnic-Anticevich S, Brough HA, Brussino L, Cardona V, Casale T, Cecchi L, Charpin D, Chivato T, Costa EM, Cruz AA, Dramburg S, Durham SR, De Feo G, Gerth van Wijk R, Fokkens WJ, Gemicioglu B, Haahtela T, Illario M, Ivancevich JC, Kvedariene V, Kuna P, Larenas-Linnemann DE, Makris M, Mathieu-Dupas E, Melén E, Morais-Almeida M, Mösges R, Mullol J, Nadeau KC, Pham-Thi N, O'Hehir R, Regateiro FS, Reitsma S, Samolinski B, Sheikh A, Stellato C, Todo-Bom A, Tomazic PV, Toppila-Salmi S, Valero A, Valiulis A, Ventura MT, Wallace D, Waserman S, Yorgancioglu A, De Vries G, van Eerd M, Zieglmayer P, Zuberbier T, Pfaar O, Almeida Fonseca J, Bousquet J. Development and validation of combined symptom-medication scores for allergic rhinitis. Allergy. 2021 Dec 21; doi: 10.1111/all.15199. Epub 2021 Dec 21. PMID: 34932829.
Copy Download .nbib Format: NLM
Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic Index.

Journal of asthma and allergy

Daley-Yates PT, Larenas-Linnemann D, Bhargave C, Verma M.
PMID: 34526783
J Asthma Allergy. 2021 Sep 08;14:1093-1104. doi: 10.2147/JAA.S321332. eCollection 2021.

Intranasal corticosteroid (INCS) therapy is the preferred treatment option for allergic rhinitis (AR). Although all INCSs for the treatment of AR are considered safe and effective, differences in potency, molecular structure features and physicochemical and pharmacokinetic properties could result...

Cite
Daley-Yates PT, Larenas-Linnemann D, Bhargave C, et al. Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic Index. J Asthma Allergy. 2021;14:1093-1104doi: 10.2147/JAA.S321332.
Daley-Yates, P. T., Larenas-Linnemann, D., Bhargave, C., & Verma, M. (2021). Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic Index. Journal of asthma and allergy, 141093-1104. https://doi.org/10.2147/JAA.S321332
Daley-Yates, Peter T, et al. "Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic Index." Journal of asthma and allergy vol. 14 (2021): 1093-1104. doi: https://doi.org/10.2147/JAA.S321332
Daley-Yates PT, Larenas-Linnemann D, Bhargave C, Verma M. Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic Index. J Asthma Allergy. 2021 Sep 08;14:1093-1104. doi: 10.2147/JAA.S321332. eCollection 2021. PMID: 34526783; PMCID: PMC8436259.
Copy Download .nbib Format: NLM
Debates in Allergy Medicine: Allergy skin testing cannot be replaced by molecular diagnosis in the near future.

The World Allergy Organization journal

Larenas-Linnemann D, Luna-Pech JA, Mösges R.
PMID: 29043011
World Allergy Organ J. 2017 Sep 19;10(1):32. doi: 10.1186/s40413-017-0164-1. eCollection 2017.

Percutaneous skin prick tests (SPT) have been considered the preferred method for confirming IgE-mediated sensitization. This reliable and minimally invasive technique correlates with in vivo challenges, has good reproducibility, is easily quantified, and allows analyzing multiple allergens simultaneously. Potent...

Cite
Larenas-Linnemann D, Luna-Pech JA, Mösges R. Debates in Allergy Medicine: Allergy skin testing cannot be replaced by molecular diagnosis in the near future. World Allergy Organ J. 2017;10(1):32doi: 10.1186/s40413-017-0164-1.
Larenas-Linnemann, D., Luna-Pech, J. A., & Mösges, R. (2017). Debates in Allergy Medicine: Allergy skin testing cannot be replaced by molecular diagnosis in the near future. The World Allergy Organization journal, 10(1), 32. https://doi.org/10.1186/s40413-017-0164-1
Larenas-Linnemann, Désirée, et al. "Debates in Allergy Medicine: Allergy skin testing cannot be replaced by molecular diagnosis in the near future." The World Allergy Organization journal vol. 10,1 (2017): 32. doi: https://doi.org/10.1186/s40413-017-0164-1
Larenas-Linnemann D, Luna-Pech JA, Mösges R. Debates in Allergy Medicine: Allergy skin testing cannot be replaced by molecular diagnosis in the near future. World Allergy Organ J. 2017 Sep 19;10(1):32. doi: 10.1186/s40413-017-0164-1. eCollection 2017. PMID: 29043011; PMCID: PMC5604190.
Copy Download .nbib Format: NLM
Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study.

The World Allergy Organization journal

Samreth D, Arnavielhe S, Ingenrieth F, Bedbrook A, Onorato GL, Murray R, Almeida R, Mizani MA, Fonseca J, Costa E, Malva J, Morais-Almeida M, Pereira AM, Todo-Bom A, Menditto E, Stellato C, Ventura MT, Larenas-Linnemann D, Fuentes-Pérez JM, Huerta-Villalobos YR, Cruz AA, Stelmach R, da Silva J, Emuzyte R, Kvedariene V, Valiulis A, Annesi-Maesano I, Bosse I, Demoly P, Devillier P, Fontaine JF, Kuna P, Samolinski B, Klimek L, Mösges R, Pfaar O, Shamai S, Bewick M, Ryan D, Sheikh A, Anto JM, Cardona V, Mullol J, Valero A, Chavannes NH, Fokkens WJ, Reitsma S, Roller-Wirnsberger RE, Tomazic PV, Haahtela T, Toppila-Salmi S, Valovirta E, Makris M, Papadopoulos NG, Prokopakis EP, Psarros F, Gemicioğlu B, Yorgancioglu A, Bindslev-Jensen C, Eller E, Kull I, Wickman M, Bachert C, Hellings PW, Pugin B, Bosnic-Anticevich S, O'Hehir RE, Kolek V, Sova M, Wehner K, De Vries G, van Eerd M, Laune D, Wittmann J, Bousquet J, Poncelet P.
PMID: 30061979
World Allergy Organ J. 2018 Jul 16;11(1):15. doi: 10.1186/s40413-018-0194-3. eCollection 2018.

BACKGROUND: Collecting data on the localization of users is a key issue for the MASK (Mobile Airways Sentinel networK: the Allergy Diary) App. Data anonymization is a method of sanitization for privacy. The European Commission's Article 29 Working Party...

Cite
Samreth D, Arnavielhe S, Ingenrieth F, et al. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study. World Allergy Organ J. 2018;11(1):15doi: 10.1186/s40413-018-0194-3.
Samreth, D., Arnavielhe, S., Ingenrieth, F., Bedbrook, A., Onorato, G. L., Murray, R., Almeida, R., Mizani, M. A., Fonseca, J., Costa, E., Malva, J., Morais-Almeida, M., Pereira, A. M., Todo-Bom, A., Menditto, E., Stellato, C., Ventura, M. T., Larenas-Linnemann, D., Fuentes-Pérez, J. M., Huerta-Villalobos, Y. R., Cruz, A. A., Stelmach, R., da Silva, J., Emuzyte, R., Kvedariene, V., Valiulis, A., Annesi-Maesano, I., Bosse, I., Demoly, P., Devillier, P., Fontaine, J. F., Kuna, P., Samolinski, B., Klimek, L., Mösges, R., Pfaar, O., Shamai, S., Bewick, M., Ryan, D., Sheikh, A., Anto, J. M., Cardona, V., Mullol, J., Valero, A., Chavannes, N. H., Fokkens, W. J., Reitsma, S., Roller-Wirnsberger, R. E., Tomazic, P. V., Haahtela, T., Toppila-Salmi, S., Valovirta, E., Makris, M., Papadopoulos, N. G., Prokopakis, E. P., Psarros, F., Gemicioğlu, B., Yorgancioglu, A., Bindslev-Jensen, C., Eller, E., Kull, I., Wickman, M., Bachert, C., Hellings, P. W., Pugin, B., Bosnic-Anticevich, S., O'Hehir, R. E., Kolek, V., Sova, M., Wehner, K., De Vries, G., van Eerd, M., Laune, D., Wittmann, J., Bousquet, J., Poncelet, P. (2018). Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study. The World Allergy Organization journal, 11(1), 15. https://doi.org/10.1186/s40413-018-0194-3
Samreth, D, et al. "Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study." The World Allergy Organization journal vol. 11,1 (2018): 15. doi: https://doi.org/10.1186/s40413-018-0194-3
Samreth D, Arnavielhe S, Ingenrieth F, Bedbrook A, Onorato GL, Murray R, Almeida R, Mizani MA, Fonseca J, Costa E, Malva J, Morais-Almeida M, Pereira AM, Todo-Bom A, Menditto E, Stellato C, Ventura MT, Larenas-Linnemann D, Fuentes-Pérez JM, Huerta-Villalobos YR, Cruz AA, Stelmach R, da Silva J, Emuzyte R, Kvedariene V, Valiulis A, Annesi-Maesano I, Bosse I, Demoly P, Devillier P, Fontaine JF, Kuna P, Samolinski B, Klimek L, Mösges R, Pfaar O, Shamai S, Bewick M, Ryan D, Sheikh A, Anto JM, Cardona V, Mullol J, Valero A, Chavannes NH, Fokkens WJ, Reitsma S, Roller-Wirnsberger RE, Tomazic PV, Haahtela T, Toppila-Salmi S, Valovirta E, Makris M, Papadopoulos NG, Prokopakis EP, Psarros F, Gemicioğlu B, Yorgancioglu A, Bindslev-Jensen C, Eller E, Kull I, Wickman M, Bachert C, Hellings PW, Pugin B, Bosnic-Anticevich S, O'Hehir RE, Kolek V, Sova M, Wehner K, De Vries G, van Eerd M, Laune D, Wittmann J, Bousquet J, Poncelet P. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study. World Allergy Organ J. 2018 Jul 16;11(1):15. doi: 10.1186/s40413-018-0194-3. eCollection 2018. PMID: 30061979; PMCID: PMC6048852.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 47 entries